{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:13:25Z","timestamp":1790820805567,"version":"4.1.0"},"reference-count":148,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00d3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00014","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T04:16:47Z","timestamp":1517804207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer"],"prefix":"10.3389","volume":"9","author":[{"given":"Gerson D.","family":"Guercio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Panizzutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(92)80397-Y","article-title":"The presence of free D-serine in rat brain","volume":"296","author":"Hashimoto","year":"1992","journal-title":"FEBS Lett"},{"key":"B2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1471-4159.1993.tb03575.x","article-title":"Embryonic development and postnatal changes in free D-aspartate and D-serine in the human prefrontal cortex","volume":"61","author":"Hashimoto","year":"1993","journal-title":"J Neurochem"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1523\/JNEUROSCI.17-05-01604.1997","article-title":"D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors","volume":"17","author":"Schell","year":"1997","journal-title":"J Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1126\/science.164.3876.142","article-title":"D-amino acids in animals","volume":"164","author":"Corrigan","year":"1969","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13409","DOI":"10.1073\/pnas.96.23.13409","article-title":"Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission","volume":"96","author":"Wolosker","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.96.2.721","article-title":"Purification of serine racemase: biosynthesis of the neuromodulator D-serine","volume":"96","author":"Wolosker","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2006.02.051","article-title":"Glia-derived D-serine controls NMDA receptor activity and synaptic memory","volume":"125","author":"Panatier","year":"2006","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature08673","article-title":"Long-term potentiation depends on release of D-serine from astrocytes","volume":"463","author":"Henneberger","year":"2010","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"14151","DOI":"10.1074\/jbc.M512927200","article-title":"Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors","volume":"281","author":"Kartvelishvily","year":"2006","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1679\/aohc.70.127","article-title":"The serine racemase mRNA is predominantly expressed in rat brain neurons","volume":"70","author":"Yoshikawa","year":"2007","journal-title":"Arch Histol Cytol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/cne.21822","article-title":"Serine racemase is predominantly localized in neurons in mouse brain","volume":"510","author":"Miya","year":"2008","journal-title":"J Comp Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10571-012-9808-4","article-title":"Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons","volume":"32","author":"Benneyworth","year":"2012","journal-title":"Cell Mol Neurobiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1096\/fj.09-147967","article-title":"Neuronal release of D-serine: a physiological pathway controlling extracellular D-serine concentration","volume":"24","author":"Rosenberg","year":"2010","journal-title":"FASEB J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10571-014-0027-z","article-title":"D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain","volume":"34","author":"Balu","year":"2014","journal-title":"Cell Mol Neurobiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00726-012-1345-4","article-title":"Structure-function relationships in human D-amino acid oxidase","volume":"43","author":"Sacchi","year":"2012","journal-title":"Amino Acids"},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuropharm.2016.08.023","article-title":"Modulating synaptic NMDA receptors","volume":"112","author":"Tovar","year":"2017","journal-title":"Neuropharmacology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1471-4159.1995.65010454.x","article-title":"Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration","volume":"65","author":"Matsui","year":"1995","journal-title":"J Neurochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1073\/pnas.97.9.4926","article-title":"D-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor","volume":"97","author":"Mothet","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.2431073100","article-title":"Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine","volume":"100","author":"Yang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41432","DOI":"10.1074\/jbc.M112.380824","article-title":"Astrocyte-induced synaptogenesis is mediated by transforming growth factor \u03b2 signaling through modulation of D-serine levels in cerebral cortex neurons","volume":"287","author":"Diniz","year":"2012","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0151233","DOI":"10.1371\/journal.pone.0151233","article-title":"D-serine and glycine differentially control neurotransmission during visual cortex critical period","volume":"11","author":"Meunier","year":"2016","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.1067020","article-title":"The molecular biology of memory storage: a dialogue between genes and synapses","volume":"294","author":"Kandel","year":"2001","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/hmg\/ddp261","article-title":"Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model","volume":"18","author":"Labrie","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.06.021","article-title":"D-serine prevents cognitive deficits induced by acute stress","volume":"86","author":"Guercio","year":"2014","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15730","DOI":"10.1073\/pnas.95.26.15730","article-title":"Modulation of N-methyl-D-aspartate receptor function by glycine transport","volume":"95","author":"Bergeron","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2005.01.062","article-title":"The pharmacological stimulation of NMDA receptors via co-agonist site: an fMRI study in the rat brain","volume":"380","author":"Panizzutti","year":"2005","journal-title":"Neurosci Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00213-010-1794-y","article-title":"D-serine and a glycine transporter-1 inhibitor enhance social memory in rats","volume":"209","author":"Shimazaki","year":"2010","journal-title":"Psychopharmacology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-011-2330-4","article-title":"Effects of low-dose D-serine on recognition and working memory in mice","volume":"218","author":"Bado","year":"2011","journal-title":"Psychopharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/schbul\/sbr084","article-title":"Neurocognitive predictors of work outcome in recent-onset schizophrenia","volume":"37","author":"Nuechterlein","year":"2011","journal-title":"Schizophr Bull"},{"key":"B31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-012-0001-4","article-title":"Cognitive impairment associated with schizophrenia: a review of the humanistic burden","volume":"29","author":"Kitchen","year":"2012","journal-title":"Adv Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1176\/ajp.155.8.1080","article-title":"Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites","volume":"155","author":"Harvey","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug \u2013 sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0269881114553647","article-title":"Recent genetic findings in schizophrenia and their therapeutic relevance","volume":"29","author":"Harrison","year":"2015","journal-title":"J Psychopharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/mp.2012.137","article-title":"Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia","volume":"18","author":"Weickert","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/mp.2008.130","article-title":"Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior","volume":"14","author":"Basu","year":"2009","journal-title":"Mol Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E2400","DOI":"10.1073\/pnas.1304308110","article-title":"Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction","volume":"110","author":"Balu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2014.10.009","article-title":"In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia","volume":"73","author":"Puhl","year":"2015","journal-title":"Neurobiol Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","article-title":"A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia","volume":"90","author":"Bendikov","year":"2007","journal-title":"Schizophr Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2012.09.014","article-title":"Plasma levels of D-serine in Brazilian individuals with schizophrenia","volume":"142","author":"Calcia","year":"2012","journal-title":"Schizophr Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"13675","DOI":"10.1073\/pnas.182412499","article-title":"Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia","volume":"99","author":"Chumakov","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ijms15010029","article-title":"The C-terminal region of G72 increases D-amino acid oxidase activity","volume":"15","author":"Chang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/mp.2013.80","article-title":"Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals","volume":"19","author":"Lin","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1017\/neu.2016.34","article-title":"Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker","volume":"29","author":"Akyol","year":"2017","journal-title":"Acta Neuropsychiatr"},{"key":"B50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.schres.2008.02.002","article-title":"Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia","volume":"101","author":"Madeira","year":"2008","journal-title":"Schizophr Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/mp.2008.47","article-title":"D-amino acid oxidase activity and expression are increased in schizophrenia","volume":"13","author":"Burnet","year":"2008","journal-title":"Mol Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.euroneuro.2007.12.002","article-title":"Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients","volume":"18","author":"Fuchs","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neulet.2016.10.006","article-title":"Low D-serine levels in schizophrenia: a systematic review and meta-analysis","volume":"634","author":"Cho","year":"2016","journal-title":"Neurosci Lett"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","article-title":"High dose D-serine in the treatment of schizophrenia","volume":"121","author":"Kantrowitz","year":"2010","journal-title":"Schizophr Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.schres.2017.02.027","article-title":"Improvement in mismatch negativity generation during D-serine treatment in schizophrenia: correlation with symptoms","volume":"191","author":"Kantrowitz","year":"2017","journal-title":"Schizophr Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S2215-0366(15)00098-X","article-title":"D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial","volume":"2","author":"Kantrowitz","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/mp.2009.99","article-title":"The neurobiology of D-amino acid oxidase and its involvement in schizophrenia","volume":"15","author":"Verrall","year":"2010","journal-title":"Mol Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.euroneuro.2007.06.006","article-title":"In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties","volume":"18","author":"Adage","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0304-3940(93)90476-2","article-title":"Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase","volume":"152","author":"Hashimoto","year":"1993","journal-title":"Neurosci Lett"},{"key":"B61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2008.08.058","article-title":"D-amino acids in rat brain measured by liquid chromatography\/tandem mass spectrometry","volume":"445","author":"Song","year":"2008","journal-title":"Neurosci Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-4347(01)00131-1","article-title":"Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity","volume":"757","author":"Morikawa","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"B63","first-page":"965","article-title":"Spatiotemporal relationships among D-serine, serine racemase, and D-amino acid oxidase during mouse postnatal development","volume":"24","author":"Wang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"B64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neures.2005.05.008","article-title":"Spatial learning and long-term potentiation of mutant mice lacking D-amino-acid oxidase","volume":"53","author":"Maekawa","year":"2005","journal-title":"Neurosci Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1101\/lm.1112209","article-title":"Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice","volume":"16","author":"Labrie","year":"2009","journal-title":"Learn Mem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00002826-198910000-00006","article-title":"Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study","volume":"12","author":"Rosse","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biol Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamapsychiatry.2014.163","article-title":"Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study","volume":"71","author":"Umbricht","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopsych.2016.11.014","article-title":"Bitopertin in negative symptoms of schizophrenia-results from the phase III FlashLyte and DayLyte studies","volume":"82","author":"Bugarski-Kirola","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/JCP.0000000000000722","article-title":"Neurophysiological effects of bitopertin in schizophrenia","volume":"37","author":"Kantrowitz","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/15622975.2015.1117654","article-title":"Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Lin","year":"2017","journal-title":"World J Biol Psychiatry"},{"key":"B76","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/ajp.156.11.1822","article-title":"D-serine added to clozapine for the treatment of schizophrenia","volume":"156","author":"Tsai","year":"1999","journal-title":"Am J Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/j.1476-5381.2011.01638.x","article-title":"Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes","volume":"165","author":"Tanahashi","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2014.08.052","article-title":"Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment","volume":"582","author":"Yamamori","year":"2014","journal-title":"Neurosci Lett"},{"key":"B79","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/npp.2012.208","article-title":"Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study","volume":"38","author":"D\u2019Souza","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.schres.2014.01.016","article-title":"D-cycloserine augmentation of cognitive remediation in schizophrenia","volume":"153","author":"Cain","year":"2014","journal-title":"Schizophr Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/BF03337739","article-title":"Prevalence of aging-associated cognitive decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer\u2019s disease (IPREA)","volume":"22","author":"Scafato","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnagi.2017.00062","article-title":"Cognitive processing speed across the lifespan: beyond the influence of motor speed","volume":"9","author":"Ebaid","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0882-7974.20.1.3","article-title":"Stability, growth, and decline in adult life span development of declarative memory: cross-sectional and longitudinal data from a population-based study","volume":"20","author":"R\u00f6nnlund","year":"2005","journal-title":"Psychol Aging"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0361073X.2013.741956","article-title":"Subjective organization, verbal learning, and forgetting across the life span: from 5 to 89","volume":"39","author":"Davis","year":"2013","journal-title":"Exp Aging Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1037\/0278-7393.15.3.507","article-title":"Effects of adult age and working memory on reasoning and spatial abilities","volume":"15","author":"Salthouse","year":"1989","journal-title":"J Exp Psychol Learn Mem Cogn"},{"key":"B86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1037\/0894-4105.14.3.409","article-title":"Age effects on executive ability","volume":"14","author":"Wecker","year":"2000","journal-title":"Neuropsychology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"d7622","DOI":"10.1136\/bmj.d7622","article-title":"Timing of onset of cognitive decline: results from Whitehall II prospective cohort study","volume":"344","author":"Singh-Manoux","year":"2012","journal-title":"BMJ"},{"key":"B88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/036107300243588","article-title":"Effects of aging on the useful field of view","volume":"26","author":"Sekuler","year":"2000","journal-title":"Exp Aging Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.cortex.2010.08.001","article-title":"Gestalt perception and the decline of global precedence in older subjects","volume":"47","author":"Staudinger","year":"2011","journal-title":"Cortex"},{"key":"B90","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7874\/jao.2015.19.1.7","article-title":"Aging and speech understanding","volume":"19","author":"Lee","year":"2015","journal-title":"J Audiol Otol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"17301","DOI":"10.1038\/srep17301","article-title":"Cognitive dysfunction and health-related quality of life among older Chinese","volume":"5","author":"Pan","year":"2015","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","article-title":"Risk factors for falls among elderly persons living in the community","volume":"319","author":"Tinetti","year":"1988","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2522\/ptj.20080117","article-title":"Increased risk of falling in older community-dwelling women with mild cognitive impairment","volume":"88","author":"Liu-Ambrose","year":"2008","journal-title":"Phys Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/geriatrics1020012","article-title":"Functional changes and driving performance in older drivers: assessment and interventions","volume":"1","author":"Karthaus","year":"2016","journal-title":"Geriatrics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1743-0003-8-2","article-title":"Gait stability and variability measures show effects of impaired cognition and dual tasking in frail people","volume":"8","author":"Lamoth","year":"2011","journal-title":"J Neuroeng Rehabil"},{"key":"B96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/syn.20004","article-title":"Aging impairs the late phase of long-term potentiation at the medial perforant path-CA3 synapse in awake rats","volume":"52","author":"Dieguez","year":"2004","journal-title":"Synapse"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1471-4159.2006.03944.x","article-title":"Age-related effects of the neuromodulator D-serine on neurotransmission and synaptic potentiation in the CA1 hippocampal area of the rat","volume":"98","author":"Junjaud","year":"2006","journal-title":"J Neurochem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.24.001.2010","article-title":"Contribution of the d-serine-dependent pathway to the cellular mechanisms underlying cognitive aging","volume":"2","author":"Potier","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neurobiolaging.2009.09.001","article-title":"Reduced serine racemase expression contributes to age-related deficits in hippocampal cognitive function","volume":"32","author":"Turpin","year":"2011","journal-title":"Neurobiol Aging"},{"key":"B100","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neurobiolaging.2008.03.010","article-title":"Preserved memory capacities in aged Lou\/C\/Jall rats","volume":"31","author":"Kollen","year":"2010","journal-title":"Neurobiol Aging"},{"key":"B101","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpba.2015.02.013","article-title":"D-serine in the aging hippocampus","volume":"116","author":"Billard","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"B102","doi-asserted-by":"publisher","first-page":"11881","DOI":"10.18632\/oncotarget.7691","article-title":"The effect of D-serine administration on cognition and mood in older adults","volume":"7","author":"Avellar","year":"2016","journal-title":"Oncotarget"},{"key":"B103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B105","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine \u2013 searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11064-014-1403-2","article-title":"Why are astrocytes important?","volume":"40","author":"Verkhratsky","year":"2015","journal-title":"Neurochem Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2174\/156720511796391917","article-title":"A\u03b2 oligomers induce glutamate release from hippocampal neurons","volume":"8","author":"Brito-Moreira","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","article-title":"A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B109","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00441-013-1789-1","article-title":"Reciprocal disruption of neuronal signaling and A\u03b2 production mediated by extrasynaptic NMDA receptors: a downward spiral","volume":"356","author":"Rush","year":"2014","journal-title":"Cell Tissue Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14336\/AD.2014.0423","article-title":"The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer\u2019s disease","volume":"6","author":"Rudy","year":"2015","journal-title":"Aging Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"14486","DOI":"10.1523\/JNEUROSCI.5034-08.2008","article-title":"NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice","volume":"28","author":"Inoue","year":"2008","journal-title":"J Neurosci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-1-2","article-title":"Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide","volume":"1","author":"Wu","year":"2004","journal-title":"J Neuroinflammation"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/tp.2015.52","article-title":"D-serine levels in Alzheimer\u2019s disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Lin","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1038\/s41598-017-13951-7","article-title":"Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e0130398","DOI":"10.1371\/journal.pone.0130398","article-title":"Cinnamon and its metabolite sodium benzoate attenuate the activation of p21rac and protect memory and learning in an animal model of Alzheimer\u2019s disease","volume":"10","author":"Modi","year":"2015","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF01318865","article-title":"Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects","volume":"15","author":"Fisher","year":"1998","journal-title":"Amino Acids"},{"key":"B118","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2016.03.017","article-title":"CSF D-serine concentrations are similar in Alzheimer\u2019s disease, other dementias, and elderly controls","volume":"42","author":"Biemans","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B119","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnins.2013.00155","article-title":"D-serine increases adult hippocampal neurogenesis","volume":"7","author":"Sultan","year":"2013","journal-title":"Front Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1474-9726.2012.00822.x","article-title":"Contribution of serine racemase\/D-serine pathway to neuronal apoptosis","volume":"11","author":"Esposito","year":"2012","journal-title":"Aging Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch Neurol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/1541-4337.12284","article-title":"Benzoate and sorbate salts: a systematic review of the potential hazards of these invaluable preservatives and the expanding spectrum of clinical uses for sodium benzoate","volume":"16","author":"Piper","year":"2017","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"B123","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","author":"Conradi","year":"2011","journal-title":"Psychol Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1600-0447.2008.01285.x","article-title":"ESEMeD\/MHEDEA 2000 investigators. Mediators of the association between depression and role functioning","volume":"118","author":"Buist-Bouwman","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"B128","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.mehy.2012.02.009","article-title":"Glutamate-based depression GBD","volume":"78","author":"McCarthy","year":"2012","journal-title":"Med Hypotheses"},{"key":"B130","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fnmol.2016.00169","article-title":"ON or OFF? Modulating the N-methyl-D-aspartate receptor in major depression","volume":"9","author":"Chan","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"CD011612","DOI":"10.1002\/14651858.CD011612.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"Caddy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B132","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression","volume":"74","author":"Huang","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1017\/S1461145711001386","article-title":"Acute D-serine treatment produces antidepressant-like effects in rodents","volume":"15","author":"Malkesman","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e67131","DOI":"10.1371\/journal.pone.0067131","article-title":"Effects of chronic D-serine elevation on animal models of depression and anxiety-related behavior","volume":"8","author":"Otte","year":"2013","journal-title":"PLoS One"},{"key":"B135","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jpsychires.2014.12.007","article-title":"Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings","volume":"61","author":"Levin","year":"2015","journal-title":"J Psychiatr Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1021\/acs.jafc.7b04217","article-title":"Acute amino acid D-serine administration, similar to ketamine, produces antidepressant-like effects through identical mechanisms","volume":"65","author":"Wei","year":"2017","journal-title":"J Agric Food Chem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2015.10.037","article-title":"Synaptic integration of adult-born hippocampal neurons is locally controlled by astrocytes","volume":"88","author":"Sultan","year":"2015","journal-title":"Neuron"},{"key":"B138","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"B139","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1101\/lm.78204","article-title":"Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications","volume":"11","author":"Richardson","year":"2004","journal-title":"Learn Mem"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/npp.2013.317","article-title":"D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial","volume":"39","author":"Difede","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B142","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-5380-3-11","article-title":"D-cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders","volume":"3","author":"Hofmann","year":"2013","journal-title":"Biol Mood Anxiety Disord"},{"key":"B143","first-page":"269","article-title":"The nature of D-serine \u2013 induced nephrotoxicity","volume":"77","author":"Ganote","year":"1974","journal-title":"Am J Pathol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/tx0500326","article-title":"D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity","volume":"18","author":"Maekawa","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tox.2004.08.008","article-title":"Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat","volume":"207","author":"Williams","year":"2005","journal-title":"Toxicology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopsych.2009.01.002","article-title":"Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine","volume":"65","author":"Hashimoto","year":"2009","journal-title":"Biol Psychiatry"},{"key":"B147","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","article-title":"Implications for reactive oxygen species in schizophrenia pathogenesis","volume":"176","author":"Koga","year":"2016","journal-title":"Schizophr Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2018.00014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T22:17:21Z","timestamp":1660429041000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2018.00014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":148,"alternative-id":["10.3389\/fpsyt.2018.00014"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00014","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"article-number":"14"}}